Better ways to see and treat aggressive prostate cancer
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
This work aims to improve how we find and treat aggressive prostate cancer using special imaging and targeted therapies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11161619 on NIH RePORTER |
What this research studies
We are exploring new ways to detect and treat prostate cancer by focusing on a specific marker called PSMA, which is often found in high amounts on cancer cells. Our goal is to refine existing PSMA-targeted imaging techniques, like PET scans, to make them even more effective for patients. We are also developing new, highly sensitive imaging methods, such as photoacoustic imaging, to better understand primary tumors and identify aggressive forms of the disease. This will help us distinguish aggressive cancers from those that are less harmful, leading to more precise care.
Who could benefit from this research
Good fit: This research is most relevant for patients diagnosed with or at risk for aggressive subtypes of prostate cancer.
Not a fit: Patients with prostate cancer that does not express PSMA or those with very early, non-aggressive forms of the disease may not directly benefit from these specific approaches.
Why it matters
Potential benefit: If successful, this work could lead to earlier and more accurate detection of aggressive prostate cancer, allowing for more effective and personalized treatment plans.
How similar studies have performed: Targeting PSMA for prostate cancer imaging and therapy has already shown significant success in nuclear medicine, and this work builds upon that foundation.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Pomper, Martin G — Ut Southwestern Medical Center
- Study coordinator: Pomper, Martin G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.